We are excited for our guests to enjoy a best-in-class experience with Passport's payment solutions and the improved operational efficiencies ...

The shift toward Cloud Solution Provider (CSP (LON:CSPC)) contracts, which bundle software with VAR support, could offer a more profitable alternative, particularly for mid-market customers ...

CSPC Pharma was already on track for a tough earnings season after its nine-month profits fell 15.9% Another blow was the sudden departure of the firm's head of innovative drug research, Liu ...

BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive License ...

CSPC is one of the largest and oldest pharmaceutical companies in China. Anchored by its nervous system business segment due to its flagship drug NBP, CSPC has a portfolio of innovative and ...

CSPC operates in a fast-growing and rapidly changing environment. Like most healthcare sectors in China, drug manufacturing has grown faster than GDP, and is projected to continue this trend over ...

Radiance Biopharma is heating up the ROR1 race. The U.S. biotech is paying (PDF) China’s CSPC Megalith Biopharmaceutical $15 million upfront for rights to an antibody-drug conjugate (ADC ...

CSPC Pharmaceutical fell 0.63 percent, Galaxy Entertainment and WuXi Biologics both skidded 1.27 percent, Haier Smart Home retreated 1.96 percent, Hang Lung Properties dropped 1.04 percent ...

Analysts widely anticipate Beijing will announce an official deficit ratio of 4% of GDP, up from the long-maintained threshold of around 3% – with notable exceptions in 2020 and 2023.

CSPC Pharmaceutical increased 0.63 percent, Galaxy Entertainment perked 0.31 percent, Haier Smart Home jumped 1.95 percent, Hang Lung Properties, Henderson Land soared 2.65 percent, JD.com ...